IVF-ART ApS: Financial statements 2024
CVR: 41526610
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
IVF-ART ApS (CVR 41526610) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -8,545 and a net result of DKK -8,545 compared with DKK -151,218 the year before. Equity in the 2024 report amounted to DKK 1,166,241. The solvency ratio was 99.4%.
- Gross Profit
- DKK -8,545
- Profit/Loss
- DKK -8,545
- Equity
- DKK 1,166,241
- Total Assets
- DKK 1,173,741
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -9 t. | -9 t. | 1.2 mio. | - |
| 2023 | - | -9 t. | -151 t. | 1.2 mio. | - |
| 2022 | - | -9 t. | -8.1 mio. | 1.3 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of November 6, 2024, Hans Kristen Krog is registered as adm. dir. of IVF-ART ApS.
IVF-ART ApS has published its annual report for 2023. Gross profit came to DKK -8,921, and the net result was DKK -151,218.
As of May 24, 2024, Solveo Statsautoriseret Revisionspartnerselskab has stepped down as auditor of IVF-ART ApS.
About IVF-ART ApS
IVF-ART ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2020. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Hans Kristen Krog and Ursula Bentin-Ley. The company is owned by Ursula Bentin-Ley. According to the 2025 annual report, the company had an average of 2 employees. In 2025, the company reported a gross profit of DKK -7,500 and a net result of DKK -7,500 compared with DKK -8,545 the year before. Equity in the 2025 report amounted to DKK 508,741.